Rodgers, T. D., Baran, A., Reagan, P. M., Casulo, C., Zent, C., Evans, A., … Barr, P. M. (2020). Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma. Br J Haematol, 188(4), e33–e36. https://doi.org/10.1111/bjh.16302

Rodgers, Thomas D., Andrea Baran, Patrick M. Reagan, Carla Casulo, Clive Zent, Andrew Evans, Richard Burack, AnnaLynn M. Williams, Jonathan W. Friedberg, and Paul M. Barr. “Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma.” Br J Haematol 188, no. 4 (February 2020): e33–36. https://doi.org/10.1111/bjh.16302.

Rodgers TD, Baran A, Reagan PM, Casulo C, Zent C, Evans A, et al. Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma. Br J Haematol. 2020 Feb;188(4):e33–6.

Rodgers, Thomas D., et al. “Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma.” Br J Haematol, vol. 188, no. 4, Feb. 2020, pp. e33–36. Pubmed, doi:10.1111/bjh.16302.

Rodgers TD, Baran A, Reagan PM, Casulo C, Zent C, Evans A, Burack R, Williams AM, Friedberg JW, Barr PM. Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma. Br J Haematol. 2020 Feb;188(4):e33–e36.